Valuation: Enovis Corporation

Market Cap 1.47B 1.29B 1.19B 1.1B 2.08B 140B 2.12B 14.23B 5.54B 68.82B 5.52B 5.4B 239B P/E 2026 *
210x
P/E 2027 * 26.4x
Enterprise Value 2.67B 2.34B 2.15B 1.99B 3.78B 255B 3.85B 25.83B 10.05B 125B 10.01B 9.79B 433B EV / Sales 2026 *
1.14x
EV / Sales 2027 * 1.03x
Free-Float
98.38%
Yield 2026 *
-
Yield 2027 * -
1 day-7.41%
1 week+14.15%
Current month+14.15%
1 month-0.63%
3 months+4.93%
6 months-14.66%
Current year-11.30%
1 week 20.23
Extreme 20.23
26.5
1 month 19.14
Extreme 19.14
26.5
Current year 19.14
Extreme 19.14
29.89
1 year 19.14
Extreme 19.14
36.82
3 years 19.14
Extreme 19.14
66.14
5 years 19.14
Extreme 19.14
164.01
10 years 19.14
Extreme 19.14
164.01
Manager TitleAgeSince
Chief Executive Officer 61 12/05/2025
Director of Finance/CFO 47 01/01/2023
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 55 13/05/2008
Director/Board Member 67 21/09/2010
Chairman 64 21/05/2025
Date Insider Type Main position Quantity % Market Cap.
30/06Free

Director

846 0.0015%
15/06Buy

Chief Administrative Officer

1,000 0.0017%
11/06Free

Chief Administrative Officer

1,000 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
-7.41%+14.15%-28.44%-63.24% 1.47B
-0.88%+3.81%-16.73%+11.07% 126B
-1.36%+3.26%+1.53%-3.22% 12.87B
+1.53%+9.44%+50.76%+120.94% 8.84B
-0.46%-0.37%-49.18%-73.25% 3.87B
-1.81%+3.71%+20.09%+40.77% 2.65B
-1.60%-2.24%-12.94%-19.85% 1.8B
-1.01%+1.33%-2.43%-25.57% 1.61B
-1.56%+10.51%-61.15%-84.17% 1.44B
Average -1.62%+4.96%-10.94%-10.72% 17.89B
Weighted average by Cap. -0.87%+4.71%-12.05%+12.18%

Financials

2026 *2027 *
Net sales 2.34B 2.05B 1.89B 1.75B 3.32B 224B 3.38B 22.71B 8.84B 110B 8.8B 8.61B 381B 2.47B 2.16B 1.99B 1.84B 3.5B 236B 3.56B 23.89B 9.3B 116B 9.26B 9.06B 401B
Net income 2.96M 2.59M 2.39M 2.21M 4.19M 283M 4.27M 28.67M 11.16M 139M 11.11M 10.87M 481M 54.22M 47.49M 43.82M 40.49M 76.83M 5.18B 78.23M 525M 204M 2.54B 204M 199M 8.81B
Net Debt 1.2B 1.05B 968M 894M 1.7B 114B 1.73B 11.6B 4.51B 56.09B 4.5B 4.4B 195B 1.07B 934M 861M 796M 1.51B 102B 1.54B 10.33B 4.02B 49.94B 4B 3.91B 173B
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
08/07/26 USD 23.63 -7.41% 1,170,291
07/07/26 USD 25.52 -1.47% 989,227
06/07/26 USD 25.90 +15.11% 2,155,004
02/07/26 USD 22.50 +12.28% 1,302,522
01/07/26 USD 20.04 -3.19% 1,502,881
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
25.52USD
Average target price
41.90USD
Spread / Average Target
+64.18%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock